353 related articles for article (PubMed ID: 24118806)
1. Neuroprotective potential of silymarin against CNS disorders: insight into the pathways and molecular mechanisms of action.
Borah A; Paul R; Choudhury S; Choudhury A; Bhuyan B; Das Talukdar A; Dutta Choudhury M; Mohanakumar KP
CNS Neurosci Ther; 2013 Nov; 19(11):847-53. PubMed ID: 24118806
[TBL] [Abstract][Full Text] [Related]
2. A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin.
Devi KP; Malar DS; Braidy N; Nabavi SM; Nabavi SF
Curr Drug Targets; 2017; 18(13):1529-1536. PubMed ID: 28025940
[TBL] [Abstract][Full Text] [Related]
3. Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms.
Haddadi R; Shahidi Z; Eyvari-Brooshghalan S
Phytomedicine; 2020 Dec; 79():153320. PubMed ID: 32920285
[TBL] [Abstract][Full Text] [Related]
4. Silibinin: a novel inhibitor of Aβ aggregation.
Yin F; Liu J; Ji X; Wang Y; Zidichouski J; Zhang J
Neurochem Int; 2011 Feb; 58(3):399-403. PubMed ID: 21185897
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
6. Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases.
Pervin M; Unno K; Ohishi T; Tanabe H; Miyoshi N; Nakamura Y
Molecules; 2018 May; 23(6):. PubMed ID: 29843466
[TBL] [Abstract][Full Text] [Related]
7. Silymarin protects neurons from oxidative stress associated damages in focal cerebral ischemia: a behavioral, biochemical and immunohistological study in Wistar rats.
Raza SS; Khan MM; Ashafaq M; Ahmad A; Khuwaja G; Khan A; Siddiqui MS; Safhi MM; Islam F
J Neurol Sci; 2011 Oct; 309(1-2):45-54. PubMed ID: 21840019
[TBL] [Abstract][Full Text] [Related]
8. Melatonin hormone as a therapeutic weapon against neurodegenerative diseases.
Asefy Z; Khusro A; Mammadova S; Hoseinnejhad S; Eftekhari A; Alghamdi S; Dablool AS; Almehmadi M; Kazemi E; Sahibzada MUK
Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):99-106. PubMed ID: 34933727
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress.
Baluchnejadmojarad T; Roghani M; Mafakheri M
Neurosci Lett; 2010 Aug; 480(3):206-10. PubMed ID: 20600617
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic potentials of milk thistle (Silybum marianum).
Milić N; Milosević N; Suvajdzić L; Zarkov M; Abenavoli L
Nat Prod Commun; 2013 Dec; 8(12):1801-10. PubMed ID: 24555302
[TBL] [Abstract][Full Text] [Related]
11. Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice.
Lu P; Mamiya T; Lu LL; Mouri A; Zou L; Nagai T; Hiramatsu M; Ikejima T; Nabeshima T
Br J Pharmacol; 2009 Aug; 157(7):1270-7. PubMed ID: 19552690
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight.
Ranjan S; Gautam A
Front Neurosci; 2023; 17():1159806. PubMed ID: 37274201
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective properties of resveratrol and derivatives.
Richard T; Pawlus AD; Iglésias ML; Pedrot E; Waffo-Teguo P; Mérillon JM; Monti JP
Ann N Y Acad Sci; 2011 Jan; 1215():103-8. PubMed ID: 21261647
[TBL] [Abstract][Full Text] [Related]
15. Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.
Ullah H; Khan H
Front Pharmacol; 2018; 9():422. PubMed ID: 29755356
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease.
Picciotto MR; Zoli M
Front Biosci; 2008 Jan; 13():492-504. PubMed ID: 17981563
[TBL] [Abstract][Full Text] [Related]
17. Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation.
Tsai MJ; Liao JF; Lin DY; Huang MC; Liou DY; Yang HC; Lee HJ; Chen YT; Chi CW; Huang WC; Cheng H
Neurochem Int; 2010 Dec; 57(8):867-75. PubMed ID: 20868716
[TBL] [Abstract][Full Text] [Related]
18. Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats.
Gupta S; Gupta YK
J Ethnopharmacol; 2017 Feb; 197():118-127. PubMed ID: 27452658
[TBL] [Abstract][Full Text] [Related]
19. Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.
Hou YC; Liou KT; Chern CM; Wang YH; Liao JF; Chang S; Chou YH; Shen YC
Phytomedicine; 2010 Oct; 17(12):963-73. PubMed ID: 20833521
[TBL] [Abstract][Full Text] [Related]
20. Silymarin versus Silibinin: Differential Antioxidant and Neuroprotective Effects against H2O2-induced Oxidative Stress in PC12 Cells.
Jiang HH; Yan FS; Shen L; Ji HF
Nat Prod Commun; 2016 May; 11(5):633-6. PubMed ID: 27319137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
